| View |
|
DRP-14384
|
Telmisartan
|
Telidril 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
| View |
|
DRP-14385
|
Telmisartan
|
TeliDril 40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
| View |
|
DRP-14386
|
Telmisartan
|
TeliDril 20
|
20 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
| View |
|
DRP-14387
|
Telmisartan
|
None
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
| View |
|
DRP-14388
|
Telmisartan
|
None
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
| View |
|
DRP-14419
|
Cefotaxime (as sodium)
|
None
|
1g
|
Powder For Injection (IM/IV)
|
Antibacterial (Third-generation Cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
04 September 2023
|
04 September 2028
|
| View |
|
DRP-14420
|
Cefotaxime (as sodium)
|
None
|
1g
|
Powder For Injection (IM/IV)
|
Antibacterial (Third-generation Cephalosporin)l
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
04 September 2023
|
04 September 2028
|
| View |
|
DR-XY48865
|
Cefotaxime (as sodium)
|
Emixon
|
1g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin
|
Vellinton Healthcare
|
India
|
Initial
|
04 September 2023
|
04 September 2028
|
| View |
|
DRMO-99
|
Medical Grade Oxygen
|
Gigagas
|
N/A
|
Compressed Medical Gas
|
Medical Gas
|
Greatwest Industrial Gases
|
Philippines
|
Initial
|
07 November 2023
|
07 November 2028
|
| View |
|
DRP-14617
|
Valproic Acid
|
Alprosant
|
250 mg/5 mL
|
Syrup
|
Antiepileptic (Fatty Acid Derivative)
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
07 November 2023
|
07 November 2028
|
| View |
|
DRP-14632
|
Vildagliptin
|
None
|
50 mg
|
Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
07 November 2023
|
07 November 2028
|
| View |
|
DRP-14616
|
Valproic Acid
|
None
|
250 mg/5 mL
|
Syrup
|
Antiepileptic (Fatty Acid Derivative)
|
Novagen Healthcare Private Limited.
|
India
|
Initial
|
07 November 2023
|
07 November 2028
|
| View |
|
DRP-14634
|
Clarithromycin
|
Clariglob
|
50 mg/mL (250 mg/5 mL)
|
Powder for Oral Suspension
(Raspberry Flavor)
|
Antibacterial (Macrolide).
|
Globela Pharma Private Limited
|
India
|
Initial
|
08 November 2023
|
08 November 2028
|
| View |
|
BRP-131
|
Trastuzumab
|
Herticad
|
150 mg
|
Powder for Concentrate for Solution for Infusion
|
Monoclonal Antibodies
|
Joint Stock Company Biocad
|
Russia
|
Initial (Reapplication)
|
09 November 2023
|
09 November 2028
|
| View |
|
BRP-130
|
Trastuzumab
|
Herticad
|
440 mg
|
Powder for Concentrate for Solution for Infusion.
|
Monoclonal Antibodies
|
Joint Stock Company Biocad
|
Russia
|
Initial (Reapplication)
|
09 November 2023
|
09 November 2028
|
| View |
|
HRP-295-01
|
Methyl Salicylate + Menthol + Camphor
|
None
|
47.36 g/ 15 g/ 9 g per 100 mL
|
Liniment
|
Counterirritant
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Automatic Renewal (E-AR)
|
22 February 2024
|
10 January 2029
|
| View |
|
HRP-299-01
|
Methyl Salicylate + Camphor + Menthol
|
None
|
14.5 g/ 4 g/ 500 mg per 100 mL
|
Liniment
|
Counterirritant
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Automatic Renewal (E-AR)
|
05 February 2024
|
15 January 2029
|
| View |
|
HRP-300-01
|
Methyl Salicylate + Camphor + Menthol
|
None
|
27.23 g / 7.5 g/ 6 g per 100 mL
|
Liniment
|
Counterirritant
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Automatic Renewal (E-AR)
|
05 February 2024
|
15 January 2029
|
| View |
|
HRP-301-01
|
Methyl Salicylate + Camphor + Menthol
|
None
|
44.4 g/ 7.5 g/ 6 g per 100 mL
|
Liniment
|
Counterirritant
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Automatic Renewal (E-AR)
|
05 February 2024
|
15 January 2029
|
| View |
|
DR-XY29386 (For Export Only)
|
Phenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol
|
Decolgen
|
10 mg / 2 mg / 500 mg
|
Tablet
|
Nasal Decongestant/ Antihistamine/ Analgesic-Antipyretic
|
UNILAB, Inc.
|
Philippines
|
Automatic Renewal (E-AR)
|
31 October 2023
|
24 February 2029
|